Anticoagulant therapies for acute venous thromboembolism among a cohort of patients discharged from Canadian urban and rural hospitals.
Tammy J BungardBruce RitchieJennifer BoltWilliam M SemchukPublished in: BMJ open (2018)
Uptake of DOAC therapy for acute VTE was modest and may have been influenced by the timing of the audit in relation to the approval of these agents for this indication. Future audits should occur to assess temporal changes and ongoing appropriateness of care delivery.
Keyphrases
- venous thromboembolism
- direct oral anticoagulants
- liver failure
- end stage renal disease
- healthcare
- respiratory failure
- newly diagnosed
- ejection fraction
- chronic kidney disease
- drug induced
- prognostic factors
- palliative care
- south africa
- atrial fibrillation
- current status
- patient reported outcomes
- pain management
- hepatitis b virus
- extracorporeal membrane oxygenation
- chronic pain
- mechanical ventilation
- patient reported